Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long-Term Clinical Outcomes
{{output}}
The long-term prognosis of immune tolerant (IT) phase patients remains unclear. This study aimed to identify true IT-phase patients with favourable outcomes and distinguish grey-zone IT patients. We retrospectively analysed 1064 chronic hepatitis B (CHB) patie... ...
